MercoPress, en Español
Montevideo, April 20th 2024 - 10:36 UTC
The Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech's COVID-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand.
Get our news on your inbox! Suscribe